- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02958657
Effect of Exercise on Platelet Reactivity After Myocardial Infarction
Effect of Exercise Training on the Autonomic Nervous System and Its Correlation With Platelet Aggregability in a Post-myocardial Infarction Population
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Introduction:
Platelet reactivity is closely involved in the pathophysiology of acute coronary syndromes (ACS). However, despite the development of newer and more effective antiplatelet drugs (among other therapeutic interventions), the risk of ischemic events recurrence after an episode of ACS is still high.
On the other hand, acute and strenuous exercise, a known trigger of ACS, when performed by untrained individuals, leads to sympathetic hyperactivity and increased platelet aggregability. Contrary to these findings, regular supervised exercise training leads to regulation of the autonomic system with consequent decrease in the incidence of ACS, as shown in previous studies. However, the relationship between regular supervised exercise training on platelet activity in patients post-AMI on dual antiplatelet therapy, has not been previously studied and is the main goal of the present project.
Objectives:
This project aims to evaluate, in recent post-AMI patients on dual antiplatelet therapy, the impact of regular exercise training on platelet aggregability, analyzed by VerifyNowP2Y12® test. Secondary exploratory analysis includes: 1) the influence of acute and strenuous exercise on platelet aggregability measured immediately after the two cardiopulmonary exercise testing (CPET) that patients will be submitted; 2) the correlation between the level of platelet aggregability and MSNA in trained and control groups; 3) the influence of exercise training on platelet aggregability measured by Multiplate® adenosine diphosphate (ADP) test and Multiplate® aspirin (ASPI) test; 4) the influence of exercise training on the mean platelet volume (MPV) and platelet count; 5) the influence of exercise training in other laboratorial parameters as lipids, blood glucose and inflammatory activity; 6) finally, the primary endpoint of the study will be evaluated in different prespecified subgroups such as diabetics, elderly, obese and patients with chronic kidney disease.
2.1. Primary endpoint of the study: Evaluate the influence of regular supervised exercise training for 3 months on platelet aggregability, analyzed by VerifyNowP2Y12® test, in patients with recent AMI utilizing dual antiplatelet therapy.
2.2. Main secondary analyses:
A. Evaluate platelet aggregability immediately after acute exercise before and after the exercise training period; for this propose, blood sample will be drawn immediately after the first and second cardiopulmonary exercise testings, in trained and control groups.
B. Correlate the platelet aggregability level, evaluated by VerifyNowP2Y12®, Multiplate-ADP®, Multiplate-ASPI®, with the level of MSNA.
2.3. Other exploratory analyses:
A. Evaluate the primary endpoint of the study utilizing Multiplate-ASPI® and Multiplate-ADP®;
B. Evaluate the MPV in trained and control groups, and its correlation with platelet aggregability;
C. Analyze, in trained and control groups, the following parameters:
Platelet count; LDL-cholesterol; HDL-cholesterol; Triglycerides; Lipid transference for HDL; Fasting glucose; Glycated hemoglobin; C-reactive protein (CRP) ultrasensitive; B-type natriuretic peptide (BNP); Troponin and Creatine Kinase MB-mass peak obtained during hospitalization; Genetic polymorphisms; Heart rate variability and spontaneous baroreflex control.
D. Analyze the primary endpoint within the following subgroups, taking into account the parameters obtained during hospitalization:
Sex (male / female); ST segment elevation myocardial infarction (STEMI) or non-STEMI; Basal heart rate (<70 or ≥ 70 bpm); History of arterial hypertension (presence or absence); LDL levels (<100 or ≥ 100 mg/dL); Age ≥65 years and <65 years; Body Mass Index <30 or ≥ 30 kg / m2; Creatinine clearance (MDRD) <60ml / min / m2 or ≥ 60 ml / min / m2; Current or not smoking; History of diabetes (present or absent); HbA1c <6.5 or ≥ 6.5%; GRACE risk score ≥140 and <140; Beta-blocker use.
- Methodology:
This is a prospective, randomized study. Patients with stable AMI admitted to a Coronary Care Unit, eligible to participate, will be randomized to a supervised exercise training program for three months at a rehabilitation unit or to a control group not formally trained. Patients who agree to participate will be included after the necessary explanations and the signature of the informed consent form.
3.a. Sample size calculation: To perform the sample calculation, previously published data wich showed platelet agreeability average of 32.9 ± 16 P2Y12 reactions units (PRU) in post-AMI patients on ticagrelor was utilizes. For an expected 35% decrease in platelet aggregability at trained group, and taking into account power of 80% and alpha index of 0.05, including 31 patients in each group is required. Admitting a percentage of losses of 40% given the difficulties inherent in the assessment of the sympathetic activity and adherence to the training program, the initial plan contemplates the inclusion of 90 patients in the study.
4. Study design: Prospective study in which eligible patients with uncomplicated AMI admitted to a Coronary Care Unit will be randomized to performing a exercise training program by three months or for an untrained control group, at a 1:1 or 1:2 rate, in order to adjust for more frequent early follow-up interruptions in exercise training group. All patients included after the necessary explanations and after signing the informed consent form. The patients will be submitted to the collection of material for laboratory evaluation including platelet aggregability tests, the assessment of a CPET in 01 and 04 months of the follow-up (end of treatment). The MSNA will be performed at the end of followup.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
SP
-
Sao Paulo, SP, Brasil, 05403-900
- Heart Institute of University of Sao Paulo Medical School
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Hospitalization for spontaneous STEMI or non-STEMI in patients older than 18 years.
Exclusion Criteria:
- Any condition that contraindicate physical activity;
- Regular exercise training practitioners prior to the ischemic event;
- Planned revascularization in the following 4 months;
- Hospitalization for cardiovascular events in the previous 12 months;
- Ventricular dysfunction, defined as left ventricular ejection fraction (LVEF) <45% on echocardiography, evaluated by Simpson's method);f) Killip class III and IV;
- High risk of arrhythmia and/or second and third degree atrioventricular block;
- Diabetes mellitus requiring intravenous insulin therapy during hospitalization;
- Important chronic kidney disease, defined by creatinine clearance<30ml/min/m2 (estimated by MDRD formula);
- Oral anticoagulation;
- Use of NSAIDs and/or dipyridamole;
- Contraindication to dual antiplatelet therapy;
- Serum hemoglobin level <10 g/dL;
- Use of glycoprotein IIB/IIIA inhibitors in the last 48 hours;
- Terminal illness;
- Liver disease or coagulopathy;
- Refusal to engage in an exercise training program.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Exercise Training
Patients randomized to the training group will start the supervised regular training program 01 month after the myocardial infarction, and it will last for three months.
|
Supervised exercise training program that includes two workouts per week for three months at a rehabilitation unit.
Otros nombres:
|
Sin intervención: Control Group
Patients in the control group will receive general instructions regarding rehabilitation post-acute myocardial infarction and will be followed for four months after the myocardial infarction.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Platelet aggregability by VerifyNow-P2Y12®
Periodo de tiempo: Before the second CPET (04 months pot-AMI)
|
To measure in recent post-AMI patients on dual antiplatelet therapy the impact of 03 months of regular exercise training (starting 30 days after the AMI) on platelet aggregability, analyzed by VerifyNow-P2Y12® test.
|
Before the second CPET (04 months pot-AMI)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Platelet aggregability by Multiplate-ADP®
Periodo de tiempo: After the first CPET (01 month post-AMI)
|
To analyze the influence of acute and strenuous exercise on platelet aggregability analysed by Multiplate-ADP® immediately after the first CPET.
|
After the first CPET (01 month post-AMI)
|
Platelet aggregability by Multiplate-ASPI®
Periodo de tiempo: After the first CPET (01 month post-AMI)
|
To analyze the influence of acute and strenuous exercise on platelet aggregability analysed by Multiplate-ASPI® immediately after the first CPET.
|
After the first CPET (01 month post-AMI)
|
Platelet aggregability by Multiplate-ADP®
Periodo de tiempo: After the second CPET (04 months post-AMI)
|
To analyze the influence of strenuous exercise on platelet aggregability measured by MultiplateADP® immediately after the second CPET.
|
After the second CPET (04 months post-AMI)
|
Platelet aggregability by Multiplate-ASPI®
Periodo de tiempo: After the second CPET (04 months post-AMI)
|
To analyze the influence of strenuous exercise on platelet aggregability measured by MultiplateASPI® immediately after the second CPET.
|
After the second CPET (04 months post-AMI)
|
Sympathetic activity by MSNA
Periodo de tiempo: Before the second CPET (04 months post-AMI)
|
To analyze the influence of exercise training on MSNA, measured by microneurography directly from the peroneal nerve and expressed by postganglionic muscle sympathetic nerve recordings burst frequency (bursts per minute).
|
Before the second CPET (04 months post-AMI)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Talia F Dalçóquio, MD, Heart Institute (InCor) University of Sao Paulo Medical School
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 12163
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Exercise Training
-
Johns Hopkins Bloomberg School of Public HealthInnovations for Poverty Action; Investors Club/Enterprise UgandaReclutamientoEstrés | Bienestar Psicológico | Dificultad económicaUganda
-
Rigshospitalet, DenmarkUniversity of CopenhagenTerminadoResultado de aprendizaje | Eficiencia de entrenamientoDinamarca
-
Queen's UniversityTerminadoEficacia del Cuaderno de Recuperación como Herramienta Psicoeducativa para Facilitar la RecuperaciónDesordenes mentalesCanadá
-
University of New HampshireAmerican Heart Association; California State University, San MarcosTerminadoModificación de la dieta | Ejercicio | Presión arterial | Promoción de la salud | Factor de riesgo cardiovascularEstados Unidos
-
Schön Klinik Berchtesgadener LandTerminadoAfección pulmonar obstructiva crónicaAlemania
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Council for Musculoskeletal HealthReclutamiento
-
Klimmendaal RevalidatiespecialistenReclutamientoLesión cerebral adquirida | Disfunción ejecutiva | Capacitación en gestión de objetivos | Capacitación en estrategia compensatoria | Juegos seriosPaíses Bajos
-
Universidad Complutense de MadridTerminado
-
Boston University Charles River CampusTerminadoDejar de fumarEstados Unidos